| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年8月 |
Biopharmaceutical Contract Manufacturing Market – Global Forecast To 2030
この調査レポートでは、バイオ医薬品受託製造市場を、サービス（製造、製剤・充填・仕上げ、包装・ラベル作成、その他）、タイプ（生物学的製剤原料製造および生物学的製剤製造）、事業規模（臨床および商業事業）、ソース（哺乳類および非哺乳類発現システム）、治療領域（腫瘍学、自己免疫疾患、代謝性疾患、心血管疾患、神経学、感染症、その他治療領域）、分子タイプ（モノクローナル抗体、抗体薬物複合体、細胞・遺伝子治療、ワクチン、治療用ペプチド・タンパク質、その他分子）、地域（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）別に分類しています。
本レポートは、バイオ医薬品受託製造市場の成長に影響を与える主要な要因（成長促進要因、阻害要因、課題、機会など）を包括的に分析しています。主要業界プレーヤーの詳細な分析も含まれており、事業概要、製品、ソリューション、主要戦略、そして協業、パートナーシップ、契約に関する洞察を提供しています。さらに、バイオ医薬品受託製造市場における新規承認・上市、合併・買収、その他の重要な活動に関する最近の動向についても取り上げています。
The global biopharmaceutical contract manufacturing market is expected to reach USD 34.15 billion by 2030 from an estimated USD 22.40 billion in 2025, at a CAGR of 8.8% from 2025 to 2030. This growth in the biopharmaceutical contract manufacturing market is primarily driven by advancements in manufacturing technologies and a growing emphasis on personalized medicine. However, evolving regulations may pose challenges that could limit market expansion.
世界のバイオ医薬品受託製造市場は、2025年の推定224億米ドルから2030年には341億5000万米ドルに達し、2025年から2030年にかけて年平均成長率（CAGR）8.8%で成長すると予測されています。バイオ医薬品受託製造市場におけるこの成長は、主に製造技術の進歩と個別化医療への関心の高まりによって牽引されています。しかしながら、規制の進化は市場拡大を制限する可能性のある課題をもたらす可能性があります。
List of Key Companies Profiled in the Report:
Key players in the biopharmaceutical contract manufacturing market include Lonza (Switzerland), Thermo Fisher Scientific Inc. (US), WuXi Biologics (China), Catalent, Inc. (US), Samsung Biologics (South Korea), Boehringer Ingelheim International GmbH (Germany), FUJIFILM Holdings Corporation (Japan), AbbVie, Inc. (US), Eurofins Scientific (Luxembourg), GenScript Biotech Corporation (US), AGC Inc. (Japan), Merck KGaA (Germany), JSR Corporation (Japan), IDT Biologika (Germany), Ajinomoto Bio-Pharma (Japan), Agilent Technologies, Inc. (US), and Asahi Kasei Corporation (Japan).
biopharmaceutical-ccontract-manufacturing-market-Overview.webp
Key Benefits of Buying the Report:
The report will assist both market leaders and new entrants by providing accurate revenue estimates for the overall biopharmaceutical contract manufacturing market and its subsegments. It will also help stakeholders better understand the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, this report will offer insights into the market’s dynamics, including key drivers, constraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (rising demand for outsourcing services, increasing demand for biologics & biosimilars, increased focus on personalized medicine, industrial collaborations for drug discovery and development/strategic partnerships and collaborations, and advancements in manufacturing technologies), restraints (challenges complying with regulatory reforms), opportunities (rising demand for cell & gene therapy, emerging countries market, and strong emphasis on drug development), and challenges (challenges to meet reformed regulations) influencing the growth of the market.
- Service Development/Innovation: Detailed insights on the upcoming technologies and research & development activities in the biopharmaceutical contract manufacturing market.
- Market Development: The report provides comprehensive information about profitable markets by analyzing them across various regions.
- Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the biopharmaceutical contract manufacturing market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, service launches/approvals, pipeline analysis, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the biopharmaceutical contract manufacturing market.